Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
proDERM is a leading contract research organization (CRO) specializing in dermatological clinical trials for the pharmaceutical, medical device, and cosmetic industries. Founded in 1994 and headquartered in Germany, the company provides a comprehensive range of services including clinical study design, execution, and advanced imaging techniques for skin, hair, and oral care research. In 2022, proDERM was acquired by SGS, the world's leading testing, inspection, and certification company, to enhance its global health and nutrition clinical trial capabilities. The institute is recognized for its high scientific standards and its ability to conduct complex Phase I-IV clinical trials and claim support studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on proDERM.